We would like to thank Dr. Denys for his insightful comments and to the Editorial Board of this Journal for offering us the opportunity to communicate a reply letter. We aim here to evaluate, comprehensively and concisely, what we believe to be essential issues concerning the use of HFJV as a motion suppression technique for abdominal ablation during extracorporeal HIFU.At the time we made the final submission of our review article [1], Denys et al. article [2] had not yet been publicly released. Moreover, no clinical experience describing the association of HIFU and HFJV techniques had been published and to the best of our knowledge, this continues to be the situation today. The reports we have cited consider the application of HFJV to radiation therapy, percutaneous thermal ablation, or extracorporeal shock wave lithotripsy. To summarize, Fritz et al. [3], working with radiotherapy, showed that HFJV enabled liver motion to be minimized to 3 mm, in agreement with Denys et al. experience. In the field of percutaneous ablation, the only series we found in literature was a retrospective observational study published in 2011 in which nine patients with hepatic or renal lesions were treated under HFJV [4]. We have also acknowledged several reports associating high frequency jet ventilation with extracorporeal shock wave lithotripsy [5-7], a technique similar to some extent to HIFU. It was shown that HFJV reduced urinary stone movement, which increased lithotripsy efficiency with better utilization of shockwave energy and less patient exposure to tissue trauma.Denys et al. study is the first prospective study for percutaneous thermal ablation with the inclusion of a large subset of patients with an intention to treat with HFJV. A real estimation of the proportion of patients noneligible for HFJV therefore can be calculated and details of the exclusion criteria are provided. Overall, their report provides detailed informations on HFJV applied to thermotherapy while we have only summarized some principles in our referenced article whose aim was to review broader topics.We agree with the observation that some lesions located in the upper part of the liver may not be treatable with extracorporeal HIFU under HFJV due to patient being ventilated in a position near of end expiration. This is a problem we have already been confronted with during conventional mechanical ventilation, since we performed sonication during the expiration phase (in sheep and pig animal studies), as it is the longest and most stable phase. Interestingly, intercostal sonication was demonstrated to be feasible [8]; however, the interposition of the right lung's inferior lobe in the HIFU beam may be a complicated problem for this configuration.Dr. Denys and his team mentioned the possibility of using HFJV for a long period of time. In the specific